abhishreshthaa
New member
SWOT ANALYSIS ON Becton, Dickinson and Company : Becton, Dickinson and Company (BD) (NYSE: BDX), is an American medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD does business in nearly 50 countries and has 29,116 employees worldwide.[2] In fiscal year ending Sep. 30 2009, 60% of BD sales were generated from non-U.S. markets.
The company's customers include healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences.[3] In 2009, BD was ranked 347 in the Fortune 500 list.
Strengths
* Innovation
* Loyal customers
* Strong management team
* Strong financial position
* Unique products
Weaknesses
* No online presence
* Poor supply chain
Opportunities
* Emerging markets and expansion abroad
* Innovation
Threats
* Competition
The company's customers include healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Diagnostics and BD Biosciences.[3] In 2009, BD was ranked 347 in the Fortune 500 list.
Strengths
* Innovation
* Loyal customers
* Strong management team
* Strong financial position
* Unique products
Weaknesses
* No online presence
* Poor supply chain
Opportunities
* Emerging markets and expansion abroad
* Innovation
Threats
* Competition
Last edited by a moderator: